Top Markets
#1 Official Trump Official Trump +50.00%
#2 Movement Movement +28.46%
#3 Mubarak Mubarak +26.88%
#4 Melania Meme Melania Meme +25.72%
#5 Zama Zama +24.72%
#6 Pearl Pearl +21.20%
#7 EXOD EXOD +18.93%
#8 Wrapped POL Wrapped POL +18.25%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.22%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +15.92%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
ImageneBio Inc ImageneBio Inc

ImageneBio Inc

IMA
Rank in Stocks #24235
ImageneBio Inc (IMA) is a biotechnology company with therapies currently... ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Share Price
$5.61
Last synced: 2026-08-21
Market Cap
$63.22M
Change (1 day)
-0.09%
Change (1 year)
-60.61%
Country
US
Trade ImageneBio Inc (IMA)

Category

Healthcare
P/S ratio for ImageneBio Inc (IMA)
P/S ratio as of 2026 TTM: 0
According to ImageneBio Inc latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for ImageneBio Inc from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH